Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04385693 · ClinicalTrials.gov registry record · NA

Intentional Pulpotomy to Preserve Hopeless Molars

A NA study, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
17
Enrollment target

NCT04385693: Completed NA study, sponsored by University of Florida.

NCT04385693 is a NA study that has completed, run by University of Florida. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04385693, a NA study, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

When proximal carious lesions of primary molars are located in close proximity to the cementum enamel junction (CEJ), marginal seal is challenging and extraction is recommended. Pulpotomy is indicated for vital primary teeth to preserve them in function. The goal of this study is to monitor the long-term effect of intentional bioactive cement pulpotomies and crown coverage performed on vital and asymptomatic carious primary molars with gingival margins close to or at the CEJ

Primary Outcome

Evaluation of asymptomatic tooth in the mouth for presence of infection (bite -wing/periapical radiograph(s)

Interventions

  • PROCEDURE Pulpotomy
  • PROCEDURE Extraction and placement of space maintainer

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2020-06-12
Est. Completion 2023-04-12
Phase NA
University of Florida

1,106 total trials

What the finished NCT04385693 record still lists

NCT04385693 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Pulpotomy is the first listed.

NCT04385693 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04385693 about?

NCT04385693 is a clinical study titled "Intentional Pulpotomy to Preserve Hopeless Molars". When proximal carious lesions of primary molars are located in close proximity to the cementum enamel junction (CEJ), marginal seal is challenging and extraction is recommended. Pulpotomy is indicated for vital primary teeth to preserve them in function. The goal of this study is to monitor the long...

What is the current status of trial NCT04385693?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2020-06-12. Estimated completion is 2023-04-12.

What interventions are being tested in trial NCT04385693?

The interventions under investigation include: Pulpotomy (PROCEDURE), Extraction and placement of space maintainer (PROCEDURE).

Who is sponsoring clinical trial NCT04385693?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04385693's enrollment target sits among peer trials

17 1871st of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04385693, the US trial registry maintained by the National Library of Medicine. NCT04385693 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.